Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Hiv Prevention topic
No spam. Unsubscribe anytime.
Committee approves bill allowing pharmacists to dispense HIV pre‑ and post‑exposure drugs under training and supervision rules
Summary
The House Health Committee voted to pass SB195, enabling pharmacists to dispense pre‑exposure and post‑exposure HIV prophylaxis under training and, in some cases, a supervising physician, with limits on supply and safeguards discussed by lawmakers.
The House Health Committee voted to pass Senate Bill 195, a measure authorizing trained pharmacists to dispense pre‑exposure prophylaxis (PrEP) and post‑exposure prophylaxis (PEP) medications for HIV under conditions described in the bill.
Senator Hostetler presented the bill, saying post‑exposure medication is most effective when started quickly and that both pre‑ and post‑exposure prophylaxis significantly reduce the risk of HIV infection. Hostetler noted that some generic options cost as little as $23 and contrasted that with the substantially higher lifetime costs of treating an HIV infection.
Representative Newton asked about the duration of pre‑exposure prophylaxis covered by the bill; Hostetler said the bill allows up to a 90‑day supply and encourages patients to obtain a health home for ongoing care. Representative Silcox and other members noted the relevance for urban areas with higher rates of new HIV infections such as Atlanta.
A committee member asked whether pharmacists could refuse to dispense the medications; Hostetler said the provision is permissive and that pharmacists could recommend a patient see a physician if they felt it was appropriate.
The committee approved the bill by voice vote; the transcript identifies Representative Newton as the House sponsor. The bill text and testimony indicate training requirements for pharmacists, a supervising‑physician requirement for injectable drugs, and liability insurance requirements for participating pharmacists.
